BioNTech (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "BioNTech" in English language version.

refsWebsite

Global rank English rank

13reuters.com

49^th place

47^th place

6fda.gov

447^th place

338^th place

5doi.org

2^nd place

5biontech.de

low place

4web.archive.org

1^st place

3nih.gov

4^th place

3worldcat.org

5^th place

3fiercebiotech.com

low place

8,828^th place

3cnbc.com

220^th place

155^th place

3bbc.com

20^th place

30^th place

3europa.eu

68^th place

117^th place

2politico.eu

1,347^th place

909^th place

2statnews.com

8,771^st place

5,253^rd place

2semanticscholar.org

11^th place

8^th place

2eib.org

7,951^st place

4,722^nd place

2globenewswire.com

2,614^th place

1,549^th place

1sec.gov

572^nd place

436^th place

1youtube.com

9^th place

13^th place

1sec.report

low place

1publishing.service.gov.uk

1,877^th place

1,129^th place

1gov.uk

432^nd place

278^th place

1canada.ca

1,712^th place

1,063^rd place

1swissmedic.ch

low place

1france24.com

481^st place

508^th place

1biontech-imfs.de

low place

1genomeweb.com

low place

1arstechnica.com

388^th place

265^th place

1forbes.hu

low place

1harvard.edu

18^th place

17^th place

1gcs-web.com

6,526^th place

4,287^th place

1archive.today

14^th place

1marketwatch.com

1,303^rd place

808^th place

1nasdaq.com

2,740^th place

2,050^th place

1metro.us

5,302^nd place

3,166^th place

1yahoo.com

38^th place

40^th place

1euractiv.com

3,286^th place

2,369^th place

1pm.gov.au

low place

1bbc.co.uk

8^th place

10^th place

1gov.hu

7,700^th place

low place

1bmj.com

1,226^th place

1,421^st place

1globalnews.ca

985^th place

583^rd place

1nytimes.com

7^th place

1dw.com

204^th place

353^rd place

1zdf.de

1,243^rd place

5,441^st place

1epharmainsider.com

low place

1fiercepharma.com

low place

8,921^st place

archive.today

Maas, Sylke; Woolford, John; Alatovic, Jasmina (16 August 2018). "BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza". BioNTech. Archived from the original on 8 December 2021. Retrieved 28 December 2022.

arstechnica.com

Mole, Beth (2 October 2023). "After being demoted and forced to retire, mRNA researcher wins Nobel". Ars Technica. Retrieved 3 October 2023.

bbc.co.uk

"Coronavirus: EU buys 300m doses of BioNTech-Pfizer vaccine". BBC News. United Kingdom. 11 November 2020. Retrieved 12 November 2020.

bbc.com

"Covid vaccine: First 'milestone' vaccine offers 90% protection". BBC News. 9 November 2020. Retrieved 22 December 2020.
Gallagher, James (20 July 2020). "Coronavirus vaccine: UK government signs deals for 90 million doses". BBC News. Retrieved 2 August 2020.
Roberts, Michelle (2 December 2020). "Covid Pfizer vaccine approved for use next week in UK". BBC. Retrieved 2 December 2020.

biontech-imfs.de

Eufets Becomes BioNTech Innovative Manufacturing Services, BioNTech IMFS, 18 September 2017, retrieved 11 November 2020

biontech.de

investors.biontech.de

"Prof. Christopher Huber". Biontech Biography. Biontech. Retrieved 5 August 2021.
"SEC Filing | BioNTech". investors.biontech.de. p. 130. Retrieved 28 December 2020.
"BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs". BioNTech. 4 September 2019. Retrieved 27 December 2020.

biontech.de

BioNTech locations, biontech.de, accessed 16 October 2022
"Aiming to address the global coronavirus pandemic: Project Lightspeed". BioNTech. 2020. Retrieved 13 December 2020.

bmj.com

Dyer, Owen (29 January 2021). "Covid-19: Countries are learning what others paid for vaccines". BMJ. 372: n281. doi:10.1136/bmj.n281. ISSN 1756-1833. PMID 33514535.

canada.ca

Pfizer-BioNTech COVID-19 vaccine: What you should know, 9 December 2020, retrieved 22 December 2020

cnbc.com

BioNTech to produce vaccines in Singapore, its new regional headquarters 10 May 2021, www.cnbc.com, accessed 16 October 2022
Lovelace Jr., Berkeley (27 July 2020). "Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday". CNBC. Retrieved 2 August 2020.
"Israel receives initial shipment of Pfizer coronavirus vaccine". CNBC. 9 December 2020. Retrieved 3 February 2021.

doi.org

Kranz, Lena M.; Diken, Mustafa; Haas, Heinrich; Kreiter, Sebastian; Loquai, Carmen (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, vol. 534, no. 7607, pp. 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227, retrieved 11 November 2020
"EU forks out € 50 million to clean Internet". Network Security. 2004 (3): 3. March 2004. doi:10.1016/s1353-4858(04)00047-9. ISSN 1353-4858.
Dyer, Owen (29 January 2021). "Covid-19: Countries are learning what others paid for vaccines". BMJ. 372: n281. doi:10.1136/bmj.n281. ISSN 1756-1833. PMID 33514535.
"UK, BioNTech test mRNA against cancer". Nature Biotechnology. 41 (2): 162. 15 February 2023. doi:10.1038/s41587-023-01693-z. PMID 36792707. S2CID 256875318.

dx.doi.org

"EU forks out € 50 million to clean Internet". Network Security. 2004 (3): 3. March 2004. doi:10.1016/s1353-4858(04)00047-9. ISSN 1353-4858.

dw.com

Welle (www.dw.com), Deutsche (8 January 2021). "COVID vaccine: EU orders 300 million more BioNTech-Pfizer doses". Deutsche Welle. Retrieved 3 February 2021.

eib.org

"BioNTech moves to head of pack for COVID-19 vaccine with EU finance". European Investment Bank. Retrieved 30 June 2021.
"BioNTech moves to head of pack for COVID-19 vaccine with EU finance". European Investment Bank. Retrieved 3 February 2021.

epharmainsider.com

"Pfizer und BioNTech bei der Oscar-Verleihung" [Pfizer and BioNTech at the Oscars]. ePharmaINSIDER. 6 April 2022. Retrieved 27 May 2022.

euractiv.com

Fortuna, Gerardo (8 January 2021). "Commission takes evasive action over Germany's vaccine side deal". euractiv.com. Retrieved 3 February 2021.

europa.eu

ec.europa.eu

"European Investment Bank provides funding of €50 million to BioNTech as part of the Investment Plan for Europe". European Commission. 17 December 2019. Retrieved 21 November 2020.
"Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing". European Commission. 11 June 2020. Retrieved 21 November 2020.

ema.europa.eu

"EMA recommends first COVID-19 vaccine for authorisation in the EU". European Medicines Agency. 21 December 2020. Retrieved 9 February 2021.

fda.gov

Commissioner, Office of the (23 August 2021). "FDA Approves First COVID-19 Vaccine". FDA. Retrieved 3 November 2021.
Vaccines and Related Biological Products Advisory Committee Meeting December 10, 2020: FDA Briefing Document – Pfizer-BioNTech COVID-19 Vaccine (Report). Retrieved 4 July 2021.
Pfizer-BioNTech COVID-19 Vaccine Frequently Asked Questions, retrieved 22 December 2020
"Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate". U.S. Food and Drug Administration (FDA) (Press release). Retrieved 20 November 2020. This article incorporates text from this source, which is in the public domain.
"Emergency Use Authorization for Vaccines Explained". U.S. Food and Drug Administration. 20 November 2020. Retrieved 20 November 2020. This article incorporates text from this source, which is in the public domain.
Commissioner, Office of the (25 June 2021). "Coronavirus (COVID-19) Update: June 25, 2021". FDA. Retrieved 30 June 2021.

fiercebiotech.com

Taylor, Nick Paul (21 September 2016). "Genentech lays $310M wager on BioNTech's mRNA cancer vaccine platform". FierceBiotech. Retrieved 7 December 2020.
"Sanofi invests €80M in BioNTech as cancer mRNA hits clinic". Fierce Pharma. 4 January 2019. Retrieved 4 November 2021.
Taylor, Nick Paul (9 July 2019). "BioNTech raises $325M series B round to advance cancer pipeline". Fierce Biotech. Archived from the original on 28 December 2022. Retrieved 28 December 2022.

fiercepharma.com

Adams, Ben (28 March 2022). "Pfizer and BioNTech go to Hollywood with splashy Oscars sponsorship". Fierce Pharma. Retrieved 27 May 2022.

forbes.hu

"Magyar kutató, hányatatott sorsú szabadalma is kellett a most bejelentett vakcinához" [Hungarian researcher, he also had to have a patent with a significant implication for the vaccine just announced]. forbes.hu (in Hungarian). 9 November 2020. Archived from the original on 26 January 2021. Retrieved 22 December 2020.

france24.com

"BioNTech's founders: scientist couple in global spotlight". France 24. 13 November 2020. Retrieved 22 December 2020.

gcs-web.com

biontechse.gcs-web.com

Maas, Sylke; Woolford, John; Alatovic, Jasmina (16 August 2018). "BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza". BioNTech. Archived from the original on 8 December 2021. Retrieved 28 December 2022.

genomeweb.com

"TheraCode to Acquire JPT Peptide Technologies". GenomeWeb. 11 May 2009. Retrieved 7 December 2020.

globalnews.ca

Katie Dangerfield (20 November 2020). "Pfizer files for emergency use of coronavirus vaccine in U.S.—what about in Canada?". Global News. Retrieved 25 November 2020.

globenewswire.com

SE, BioNTech (15 September 2020). "BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162". GlobeNewswire News Room. Retrieved 3 February 2021.
SE, BioNTech (5 August 2020). "Pfizer and BioNTech to Supply Canada with their BNT162 mRNA-Based Vaccine Candidate". GlobeNewswire News Room. Retrieved 3 February 2021.

gov.hu

koronavirus.gov.hu

"Az Európai Gyógyszerügynökség forgalmazásra ajánlja a Pfizer/BioNTech-vakcinát". koronavirus.gov.hu (in Hungarian). 21 December 2020. Retrieved 22 December 2020.

gov.uk

"UK medicines regulator gives approval for first UK COVID-19 vaccine". Government of the United Kingdom. 2 December 2020. Retrieved 2 December 2020.

harvard.edu

ui.adsabs.harvard.edu

Kranz, Lena M.; Diken, Mustafa; Haas, Heinrich; Kreiter, Sebastian; Loquai, Carmen (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, vol. 534, no. 7607, pp. 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227, retrieved 11 November 2020

marketwatch.com

Keown, Callum; Saigol, Lina (8 December 2020). "Here are 5 things to know about BioNTech and the married couple behind the COVID-19 vaccine developed with Pfizer". MarketWatch. Archived from the original on 29 December 2022. Retrieved 29 December 2022.

metro.us

BioNTech to build mRNA vaccine manufacturing site in Singapore 10 May 2021, www.metro.us, accessed 16 October 2022

nasdaq.com

BioNTech SE, NASDAQ, retrieved 12 November 2020

nih.gov

pubmed.ncbi.nlm.nih.gov

Kranz, Lena M.; Diken, Mustafa; Haas, Heinrich; Kreiter, Sebastian; Loquai, Carmen (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, vol. 534, no. 7607, pp. 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227, retrieved 11 November 2020
Dyer, Owen (29 January 2021). "Covid-19: Countries are learning what others paid for vaccines". BMJ. 372: n281. doi:10.1136/bmj.n281. ISSN 1756-1833. PMID 33514535.
"UK, BioNTech test mRNA against cancer". Nature Biotechnology. 41 (2): 162. 15 February 2023. doi:10.1038/s41587-023-01693-z. PMID 36792707. S2CID 256875318.

nytimes.com

Benjamin Mueller (2 December 2020). "U.K. Approves Pfizer coronavirus vaccine, a first in the West". The New York Times. Retrieved 2 December 2020.

pm.gov.au

"Australia Secures a further 50 Million Doses of COVID-19 Vaccine | Prime Minister of Australia". www.pm.gov.au. Retrieved 3 February 2021.

politico.eu

"Commission approves BioNTech/Pfizer vaccine". Politico. 21 December 2020. Retrieved 22 December 2020.
"Belgian secretary of state accidentally reveals EU vaccine prices". Politico. 17 December 2020. Retrieved 22 December 2020.

publishing.service.gov.uk

assets.publishing.service.gov.uk

"Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine" (PDF). Government of the United Kingdom. 2 December 2020. Retrieved 2 December 2020.

reuters.com

Spalding, Rebecca; Franklin, Joshua (9 October 2019). "Germany's BioNTech raises $150 million in smaller-than-planned U.S. IPO amid market volatility". Reuters. Retrieved 7 December 2020.
Burger, Ludwig; Jain, Pratik; Leo, Leroy (10 January 2023). "Germany's BioNTech buys British AI startup InstaDeep". Reuters.
BioNTech buys German site from Novartis to boost vaccine output Reuters 17 September 2020
Burger, Ludwig (15 March 2020). "BioNTech in China alliance with Fosun over coronavirus vaccine candidate". Reuters. Retrieved 22 July 2021.
Burger, Ludwig (29 June 2020). "Temasek-led investor group in $250 million vaccine bet on Germany's BioNTech". Reuters. Frankfurt. Retrieved 2 August 2020.
"BioNTech in China alliance with Fosun over coronavirus vaccine candidate". Reuters. Frankfurt. 15 March 2020. Retrieved 2 August 2020.
Burger, Ludwig (22 April 2020). "Germany approves trials of COVID-19 vaccine candidate". Reuters. Berlin. Retrieved 2 August 2020.
Shakil, Ismail; Mishra, Manas (31 July 2020). "Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan". Reuters. Bengaluru. Retrieved 3 August 2020.
Erman, Michael; Banerjee, Ankur (22 July 2020). "U.S. to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccine". Reuters. Retrieved 2 August 2020.
Smout, Alistair (20 July 2020). "Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, Valneva". Reuters. London. Retrieved 2 August 2020.
"Fosun Pharma to buy 100 million doses of BioNTech's COVID-19 vaccine for mainland China". Reuters. 16 December 2020. Retrieved 3 February 2021.
Binnie, Anita Komuves, Benoit Van Overstraeten, Isla (27 December 2020). "'Window of hope': Europe begins to launch COVID-19 vaccinations". Reuters. Retrieved 27 December 2020.{{cite news}}: CS1 maint: multiple names: authors list (link)
"FDA adds warning about rare heart inflammation to Pfizer, Moderna COVID shots". Reuters. 26 June 2021. Retrieved 30 June 2021.

sec.gov

"BioNTech 2023 Annual Report (Form 20-F)". U.S. Securities and Exchange Commission. 20 March 2024. Retrieved 24 June 2023.

sec.report

BioNTech SE (9 September 2019), Form F-1, U.S. Securities and Exchange Commission, archived from the original on 14 February 2021, retrieved 23 September 2020

semanticscholar.org

api.semanticscholar.org

Kranz, Lena M.; Diken, Mustafa; Haas, Heinrich; Kreiter, Sebastian; Loquai, Carmen (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, vol. 534, no. 7607, pp. 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227, retrieved 11 November 2020
"UK, BioNTech test mRNA against cancer". Nature Biotechnology. 41 (2): 162. 15 February 2023. doi:10.1038/s41587-023-01693-z. PMID 36792707. S2CID 256875318.

statnews.com

"The story of mRNA: From a loose idea to a tool that may help curb Covid". STAT. 10 November 2020. Retrieved 19 June 2021.
Helen Branswell (20 November 2020). "Pfizer, BioNTech submit formal application to FDA to authorize Covid-19 vaccine". STAT. Retrieved 25 November 2020.

swissmedic.ch

Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland, retrieved 22 December 2020

web.archive.org

BioNTech SE (9 September 2019), Form F-1, U.S. Securities and Exchange Commission, archived from the original on 14 February 2021, retrieved 23 September 2020
"Magyar kutató, hányatatott sorsú szabadalma is kellett a most bejelentett vakcinához" [Hungarian researcher, he also had to have a patent with a significant implication for the vaccine just announced]. forbes.hu (in Hungarian). 9 November 2020. Archived from the original on 26 January 2021. Retrieved 22 December 2020.
Taylor, Nick Paul (9 July 2019). "BioNTech raises $325M series B round to advance cancer pipeline". Fierce Biotech. Archived from the original on 28 December 2022. Retrieved 28 December 2022.
Keown, Callum; Saigol, Lina (8 December 2020). "Here are 5 things to know about BioNTech and the married couple behind the COVID-19 vaccine developed with Pfizer". MarketWatch. Archived from the original on 29 December 2022. Retrieved 29 December 2022.

worldcat.org

Kranz, Lena M.; Diken, Mustafa; Haas, Heinrich; Kreiter, Sebastian; Loquai, Carmen (16 June 2016), "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy", Nature, vol. 534, no. 7607, pp. 396–401, Bibcode:2016Natur.534..396K, doi:10.1038/nature18300, ISSN 1476-4687, PMID 27281205, S2CID 38112227, retrieved 11 November 2020
"EU forks out € 50 million to clean Internet". Network Security. 2004 (3): 3. March 2004. doi:10.1016/s1353-4858(04)00047-9. ISSN 1353-4858.
Dyer, Owen (29 January 2021). "Covid-19: Countries are learning what others paid for vaccines". BMJ. 372: n281. doi:10.1136/bmj.n281. ISSN 1756-1833. PMID 33514535.

yahoo.com

finance.yahoo.com

"BioNTech Completes Acquisition of InstaDeep". Yahoo Finance (Press release). 31 July 2023. Retrieved 1 August 2023.

youtube.com

"BioNTech CEO on vaccine progress with Pfizer – YouTube". Retrieved 14 June 2021 – via YouTube.

zdf.de

"Krebs-Impfstoffe: Biontech plant Therapieansatz vor 2030". ZDFheute (in German). Retrieved 26 November 2023.